Relevance of the combination of external beam radiotherapy with the hypoxia-activated prodrug ICF05016 in an experimental model of extraskeletal myxoid chondrosarcoma.

MLA

Maubert, Elise, et al. “Relevance of the Combination of External Beam Radiotherapy with the Hypoxia-Activated Prodrug ICF05016 in an Experimental Model of Extraskeletal Myxoid Chondrosarcoma.” Investigational New Drugs, vol. 39, no. 2, Apr. 2021, pp. 295–303. EBSCOhost, https://doi.org/10.1007/s10637-020-01002-4.

APA

Maubert, E., Weber, V., Voissière, A., Gérard, Y., Dedieu, V., Degoul, F., Chezal, J.-M., Chautard, E., & Miot-Noirault, E. (2021). Relevance of the combination of external beam radiotherapy with the hypoxia-activated prodrug ICF05016 in an experimental model of extraskeletal myxoid chondrosarcoma. Investigational New Drugs, 39(2), 295–303. https://doi.org/10.1007/s10637-020-01002-4

Chicago

Maubert, Elise, Valérie Weber, Aurélien Voissière, Yvain Gérard, Véronique Dedieu, Françoise Degoul, Jean-Michel Chezal, Emmanuel Chautard, and Elisabeth Miot-Noirault. 2021. “Relevance of the Combination of External Beam Radiotherapy with the Hypoxia-Activated Prodrug ICF05016 in an Experimental Model of Extraskeletal Myxoid Chondrosarcoma.” Investigational New Drugs 39 (2): 295–303. doi:10.1007/s10637-020-01002-4.